Sixty other CUNY projects have also received stop-work orders from the National Institute of Health, according to a letter ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

Despite steep budget and staffing cuts at the FDA in recent weeks and other headwinds, Gilead CEO Daniel O’Day assured investors that the pharma’s plans and preparations for lenacapavir’s launch ...

The National Institutes of Health’s sweeping cuts of grants that fund scientific research are inflicting pain almost ...

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

Sales of cancer drug Trodelvy fell 5% to $293 million, below analysts' estimates of $362 million, due to pricing and ...

SPRINGFIELD The Illinois Department of Public Health (IDPH) has issued a standing order that will allow Illinoisans to obtain ...

Amanda Bleichrodt, MPH, discusses her team’s findings that the US is unlikely to reach the Ending the HIV Epidemic goal of a 90% drop in HIV incidence by 2030.

A standing order from the Illinois Department of Public Health allows residents to get PrEP, HIV preventative medication, ...

A new study is part of a growing body of evidence that vaccination against shingles—and potentially other infections—can be protective against developing dementia. While there is currently no ...

Long-acting injectable HIV treatment leads to rectal shedding in a small proportion of patients with HIV, independent of the oral lead-in phase.

Data from the last five years show that many people who contracted HIV had seen a provider in the year before.